MedTrace Logo

Morphine Versus Ketorolac in Low Back Pain

NCT02782286 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2016-05-25

No results posted yet for this study

Summary

The study is prospective, double blinded, randomised controlled and has the purpose to compare the analgesic effects of ketorolac or morphine intravenous in low back pain.

Conditions

  • Low Back Pain

Interventions

DRUG

Ketorolac

The patients randomised to this arm will receive 30 mg intravenous ketorolac.

DRUG

Morphine

The patients randomised to this arm will receive 0,1 mg/kg intravenous morphine.

Sponsors & Collaborators

  • Loredana Ghinea

    lead OTHER

Principal Investigators

  • Dan Marinescu, MD · Clinical Emergency Hospital Bucharest

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2016-09-30
Completion
2016-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02782286 on ClinicalTrials.gov